Back to Search
Start Over
Biologics in shoulder and elbow pathology
- Source :
- JSES Reviews, Reports, and Techniques, Vol 1, Iss 1, Pp 1-6 (2021)
- Publication Year :
- 2021
- Publisher :
- Elsevier, 2021.
-
Abstract
- In recent years, orthobiologics have been of increasing clinical interest in the treatment of shoulder and elbow pathology. In some conditions, such as rotator cuff injury and lateral epicondylitis, there have been high-quality trials that support the use of platelet-rich plasma in reducing pain, restoring functionality, and improving clinical outcomes. However, as the numbers of both cellular-based biologics and the conditions being augmented by biologics continue to expand, there is a substantial need for high-quality investigations to support their routine use in most shoulder and elbow conditions. The purpose of this review is to summarize the current evidence of orthobiologics in the management of shoulder and elbow injury, as nonoperative treatment and as augments to operative treatment.
- Subjects :
- Review Article
Surgery
RD1-811
Subjects
Details
- Language :
- English
- ISSN :
- 26666391
- Volume :
- 1
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- JSES Reviews, Reports, and Techniques
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.970c4e1bcbb045a5acde89a64298bbe3
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.xrrt.2020.11.002